SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001104659-21-022719
Filing Date
2021-02-16
Accepted
2021-02-16 07:02:33
Documents
1
Group Members
ROCHE HOLDING LTD

Document Format Files

Seq Description Document Type Size
1 SC 13G tm216688d5_sc13g.htm SC 13G 72586
  Complete submission text file 0001104659-21-022719.txt   74184
Mailing Address C/O HOFFMAN LA ROCHE 124 GRENSACHERSTRASSE CH 4002 BASEL SWITZERLAND V8
Business Address C/O HOFFMAN LA ROCHE 124 GRENSACHERSTRASSE CH 4002 BASEL SWITZERLAND V8
ROCHE FINANCE LTD (Filed by) CIK: 0001053942 (see all company filings)

State of Incorp.: V8
Type: SC 13G

Mailing Address 134 COOLIDGE AVENUE 2ND FLOOR WATERTOWN MA 02472
Business Address 134 COOLIDGE AVENUE 2ND FLOOR WATERTOWN MA 02472 617-393-5925
Pandion Therapeutics, Inc. (Subject) CIK: 0001807901 (see all company filings)

IRS No.: 833015614 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-91578 | Film No.: 21632299
SIC: 2834 Pharmaceutical Preparations